News Conference News TCT 2022 Pascal TEER Device Performs Well in Patients With Complex Anatomy Yael L. Maxwell September 26, 2022
News Conference News TCT 2022 Valve Fracture for ViV TAVI Linked With Higher Mortality Michael O'Riordan September 22, 2022
News Conference News TCT 2022 Mix of Patient, Procedural, and Device Factors All Drove TAVI Advances Caitlin E. Cox September 19, 2022
News Conference News TCT 2022 Ultrasound for Femoral Access? Neutral Results vs Common Sense: UNIVERSAL Yael L. Maxwell September 19, 2022
Presentation TCT 2022 TCT 103: Impact of pre-existing and new atrial fibrillation on major adverse cardiac events following coronary revascularization Presenter: Omar Abdel-Razek September 18, 2022
News Conference News TCT 2022 Sizing Mismatch a Problem for Balloon-Expandable Valves in Small Annuli TAVI Yael L. Maxwell September 18, 2022
News Conference News TCT 2022 Amulet, Watchman 2.5 LAAO Devices Provide Comparable 3-Year Outcomes Todd Neale September 18, 2022
News Conference News TCT 2022 As Time Goes By, Post-TAVI Thrombus Becomes More OAC Resistant Michael O'Riordan September 18, 2022
Presentation TCT 2022 TCT 381: Vitamin K Antagonists, Direct Oral Anticoagulants, or Left Atrial Appendage Closure for Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Network Meta-Analysis Presenter: Davide Cao September 18, 2022
News Conference News TCT 2022 TRILUMINATE Pivotal Trial: First Data Support Safety, Efficacy of TriClip Caitlin E. Cox September 17, 2022
Presentation TCT 2022 TCT 1: Bleeding in Patients with Atrial Fibrillation and Acute Coronary Syndrome or PCI treated with Antithrombotic Therapy: Insights from the AUGUSTUS Trial Presenter: Dennis Narcisse September 17, 2022
Presentation TCT 2022 TCT 20: Relative benefit of double versus triple antithrombotic therapy in patients with atrial fibrillation randomized earlier versus later after index coronary event: Insights from the AUGUSTUS Trial Presenter: Alexander Fanaroff September 17, 2022